Hostname: page-component-f554764f5-8cg97 Total loading time: 0 Render date: 2025-04-20T18:14:34.874Z Has data issue: false hasContentIssue false

359 Differentiating opioid use disorder from healthy controls via ML analysis of rs-fMRI networks

Published online by Cambridge University Press:  11 April 2025

Ahmed Temtam
Affiliation:
Vision Lab, Dept. of Electrical Engineering, Old Dominion University, Norfolk, VA, USA
Megan A. Witherow
Affiliation:
Vision Lab, Dept. of Electrical Engineering, Old Dominion University, Norfolk, VA, USA
Liangsuo Ma
Affiliation:
Institute of Drug and Alcohol Studies, Richmond, VA, USA, Department of Psychiatry
M Shibly Sadique
Affiliation:
Vision Lab, Dept. of Electrical Engineering, Old Dominion University, Norfolk, VA, USA
F. Gerard Moeller
Affiliation:
Institute of Drug and Alcohol Studies, Richmond, VA, USA, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA, Department of Neurology, Virginia Commonwealth University, VA, United States
C. Kenneth
Affiliation:
Virginia Commonwealth University, Richmond, VA, USA
Dianne Wright
Affiliation:
Center for Clinical and Translational Research, Virginia Commonwealth University, VA, United States
Khan M. Iftekharuddin
Affiliation:
Dept. Of Electrical Engineering, Old Dominion University, Norfolk, VA, USA,Data Science Institute, Old Dominion University, Virginia Beach, VA, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Objectives/Goals: This work aims to identify functional brain networks that differentiate opioid use disorder (OUD) subjects from healthy controls (HC) using machine learning (ML) analysis of resting-state fMRI (rs-fMRI). We investigate the default mode network (DMN), salience network (SN), and executive control network (ECN), as well as demographic features. Methods/Study Population: This work uses high-resolution rs-fMRI data from a National Institute on Drug Abuse study (IRB #HM20023630) with 31 OUD and 45 HC subjects. We extract rs-fMRI blood oxygenation level-dependent (BOLD) features from the DMN, SN, and ECN. The Boruta ML algorithm identifies statistically significant features and brain activity mapping visualizes regions of heightened neural activity for OUD. We conduct fivefold cross-validation classification experiments (OUD vs. HC) to assess the discriminative power of functional network features with and without incorporating demographic features. Demographic features are ranked based on ML classification importance. Follow-up Boruta analysis is performed to study the medial prefrontal cortex (mPFC), posterior cingulate cortex, and temporoparietal junctions in the DMN. Results/Anticipated Results: Boruta ML analysis identifies the DMN as the most salient functional network for differentiating OUD from HC, with 33% of DMN features found significant (p < 0.05), compared to 10% and 0% for the SN and ECN, respectively. The Boruta ML algorithm identifies age and education as the most significant demographic features. Brain activity mapping shows heightened neural activity in the DMN for OUD. The DMN exhibits the greatest discriminative power, with a mean AUC of 69.74%, compared to 47.14% and 54.15% for the SN and ECN, respectively. Fusing DMN BOLD features with the most important demographic features improves the mean AUC to 80.91% and the F1 score to 73.97%. Follow-up Boruta analysis highlights the mPFC as the most important functional hub within the DMN, with 65% significant features. Discussion/Significance of Impact: Our study enhances the understanding of OUD neurobiology, identifying the DMN as the most significant network using ML rs-fMRI BOLD feature analysis. Ethnicity, education, and age rank are the most important demographic features and the mPFC emerges as a key functional hub for OUD. Future research can build on these findings to inform treatment of OUD.

Type
Informatics, AI and Data Science
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2025. The Association for Clinical and Translational Science